Mona Ashiya Gemini Therapeutics, Inc. (GMTX) insider trading activity

GMTX Quotes by TradingView

Mona Ashiya is Director of Gemini Therapeutics, Inc. . Currently has a direct ownership of 0 shares of GMTX, which is worth approximately $0. The most recent transaction as insider was on Dec 18, 2023, when has been sold 1,724 shares (Common Stock) at a price of $59.24 per share, resulting in proceeds of $102,129. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Mona Ashiya Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 18 2023
SELL
Open market or private sale
$102,129 $59.24 p/Share
1,724 Reduced 100.0%
0 Common Stock
Dec 18 2023
BUY
Exercise of conversion of derivative security
$65,512 $38.0 p/Share
1,724 Added 50.0%
1,724 Common Stock

Also insider at

SRRA
Sierra Oncology, Inc. Healthcare
Director
MA

Mona Ashiya

Director
San Mateo, CA

Track Institutional and Insider Activities on GMTX

Follow Gemini Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GMTX shares.

Notify only if

Insider Trading

Get notified when an Gemini Therapeutics, Inc. insider buys or sells GMTX shares.

Notify only if

News

Receive news related to Gemini Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on GMTX